Evidence map›Paper›PMID 42771104›Full record

ArticleClinical rheumatology2026

Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis/polymyositis.

Cuirong Ba, Chunguo Jiang, Yanli Gao, Qiuhong Fang

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cuirong BaDepartment of General Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
Chunguo JiangDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongren Tiyuchang South Road, Chaoyang District, Beijing, 100020, China.
Yanli GaoDepartment of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Qiuhong FangDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongren Tiyuchang South Road, Chaoyang District, Beijing, 100020, China. fangmaster123@163.com.ORCID http://orcid.org/0000-0003-3012-8008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION/

objectivesAcute exacerbation of interstitial lung disease secondary to dermatomyositis or polymyositis (DM/PM-AEILD) is an intractable, life-threatening disease with unsatisfactory therapeutic efficacy, particularly in patients positive for anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody (Ab). Identifying prognostic risk factors for DM/PM-AEILD might help clinicians to stratify high-risk patients at an early stage and deliver targeted standardized treatment.

methodsWe retrospectively collected clinical data of 35 hospitalized patients diagnosed with DM/PM-AEILD, including 18 patients with anti-MDA5-Ab

resultsThe cohort consisted of 21 females and 14 males; the mean age was 62.11 ± 10.78 years. The overall in-hospital mortality of DM/PM-AEILD reached 42.9%, and the mortality climbed to 66.7% among anti-MDA5 Ab

conclusionsPatients hospitalized with DM/PM-AEILD suffer high in-hospital mortality, which is further elevated in anti-MDA5 Ab

Indexed as

Anti-MDA5 antibodyDermatomyositisInterstitial lung diseasePolymyositis

Identifiers

PMID42771104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.